Hyponatraemia is the most common electrolyte abnormality among hospital inpatients, with clinical manifestations ranging from ...
Diagnosis delays in primary hyperoxalurias have halved in France over five years, potentially enabling earlier management.
Fruquintinib combined with FOLFIRI/mFOLFOX6 as second-line treatment in patients with RAS-mutant metastatic colorectal cancer (mCRC): A multicenter, open-label, phase II study. This is an ASCO Meeting ...
In order to address the specific details and regulatory requirements present in a retrospective medical chart review, the UB IRB recently created a new Protocol template: the HRP-503R. In order to ...
Impact of KRAS mutation status on outcomes in peritoneal metastatic mucinous adenocarcinoma of the colon and appendix following CRS-HIPEC: A retrospective analysis. The addition of monoclonal ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results